<DOC>
	<DOC>NCT02334787</DOC>
	<brief_summary>To assess the safety (especially skin findings) and pharmacokinetics by applying 0.3%, 1%, or 3% formulation of 5g OPA-15406 ointment to a 1000 cm2 area as a single-dose and as a multiple-dose twice daily for 2 weeks in Japanese healthy adult male subjects.</brief_summary>
	<brief_title>A Phase 1 Trial of OPA-15406 Ointment in Healthy Adult Male Subjects</brief_title>
	<detailed_description />
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Dermatitis, Atopic</mesh_term>
	<mesh_term>Eczema</mesh_term>
	<criteria>BMI = Body weight (kg) / [Height (m)]2: at least 18.5 and less than 25.0 Judged by the investigator or subinvestigator to be healthy based on test results at screening and prior to administration on Day 1 of the treatment period Findings (sunburn, abrasions, tattoos, etc) on the back that affect the evaluation of the safety of the skin Judged by the investigator or subinvestigator as inappropriate to participate in this trial for any other reasons</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>